𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of atypical antipsychotics for treatment-resistant major depressive disorder

✍ Scribed by George I. Papakostas; Richard C. Shelton

Book ID
107552041
Publisher
Springer
Year
2008
Tongue
English
Weight
247 KB
Volume
10
Category
Article
ISSN
1523-3812

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The combination of duloxetine and buprop
The combination of duloxetine and bupropion for treatment-resistant major depressive disorder
✍ George I. Papakostas; John J. Worthington III; Dan V. Iosifescu; Gustavo Kinrys; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

Our objective was to assess the effectiveness and safety of the combination of duloxetine and bupropion for treatment-resistant major depressive disorder (TRD). A retrospective chart review was conducted to identify patients with major depressive disorder (MDD) who had not experienced full remission

Effect of augmented atypical antipsychot
Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting
✍ Ho-Jun Seo; Young-Eun Jung; Young Sup Woo; Tae-Youn Jun; Jeong-Ho Chae; Won-Myon πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 1 views

## Abstract ## Objective The extent of weight changes in depressed patients who use atypical antipsychotics (AAP) as augmentation could not be easily predicted due to weight related symptoms of depression and the interaction with antidepressants which have weight reducing effects. ## Methods Pat